VR Logo

Ankur Drugs & Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011


Value Research Stock Advisor has just released a new stock recommendation. You can click here to learn more about this premium service, and get immediate access to the live recommendations, plus new ones as soon as they are issued.

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Purnandu Jain HUF